Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
- 4 July 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 18 (8), 1022-1039
- https://doi.org/10.1016/s1470-2045(17)30445-x
Abstract
No abstract availableKeywords
Funding Information
- European Commission through the Consumers, Health, Agriculture and Food Executive Agency (Grant No. 2000111201)
This publication has 19 references indexed in Scilit:
- Funnel plots for population-based cancer survival: principles, methods and applicationsStatistics in Medicine, 2013
- Improving methodology to go beyond histology in rare cancersThe Lancet Oncology, 2013
- Endocrine Tumours: Epidemiology of malignant digestive neuroendocrine tumoursActa Endocrinologica, 2013
- Oesophageal cancer survival in Europe: A EUROCARE-4 studyCancer Epidemiology, 2012
- Human papillomavirus related head and neck cancer survival: A systematic review and meta-analysisOral Oncology, 2012
- Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experienceBlood, 2012
- Rare cancers are not so rare: The rare cancer burden in EuropeEuropean Journal of Cancer, 2011
- Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortiumInternational Journal of Epidemiology, 2009
- Recent changes in the epidemiology of head and neck cancerCurrent Opinion in Oncology, 2009
- Impact of Volume and Specialization for Cancer SurgeryDigestive Surgery, 2004